Insurance - Brokers
Compare Stocks
2 / 10Stock Comparison
CRVL vs AMSF
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
CRVL vs AMSF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Brokers | Insurance - Specialty |
| Market Cap | $2.98B | $569M |
| Revenue (TTM) | $941M | $325M |
| Net Income (TTM) | $106M | $46M |
| Gross Margin | 24.2% | 47.6% |
| Operating Margin | 14.5% | 17.8% |
| Forward P/E | 33.4x | 14.4x |
| Total Debt | $28M | $491K |
| Cash & Equiv. | $171M | $62M |
CRVL vs AMSF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CorVel Corporation (CRVL) | 100 | 256.6 | +156.6% |
| AMERISAFE, Inc. (AMSF) | 100 | 49.4 | -50.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRVL vs AMSF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRVL is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.48
- Rev growth 12.6%, EPS growth 24.5%, 3Y rev CAGR 11.5%
- 267.5% 10Y total return vs AMSF's 31.8%
AMSF carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- Beta 0.23, yield 8.4%, current ratio 0.32x
- Lower P/E (14.4x vs 33.4x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.6% revenue growth vs AMSF's 2.6% | |
| Value | Lower P/E (14.4x vs 33.4x) | |
| Quality / Margins | Combined ratio 0.8 vs CRVL's 0.9 (lower = better underwriting) | |
| Stability / Safety | Beta 0.23 vs CRVL's 0.48, lower leverage | |
| Dividends | 8.4% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | -29.2% vs CRVL's -47.9% | |
| Efficiency (ROA) | 16.4% ROA vs AMSF's 5.6%, ROIC 51.3% vs 21.9% |
CRVL vs AMSF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CRVL vs AMSF — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CRVL is the larger business by revenue, generating $941M annually — 2.9x AMSF's $325M. Profitability is closely matched — net margins range from 14.3% (AMSF) to 11.2% (CRVL). On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $941M | $325M |
| EBITDAEarnings before interest/tax | $168M | $58M |
| Net IncomeAfter-tax profit | $106M | $46M |
| Free Cash FlowCash after capex | $69M | $8M |
| Gross MarginGross profit ÷ Revenue | +24.2% | +47.6% |
| Operating MarginEBIT ÷ Revenue | +14.5% | +17.8% |
| Net MarginNet income ÷ Revenue | +11.2% | +14.3% |
| FCF MarginFCF ÷ Revenue | +7.3% | +2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.4% | +10.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.2% | -8.5% |
Valuation Metrics
AMSF leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 61% valuation discount to CRVL's 31.7x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than CRVL's 18.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.0B | $569M |
| Enterprise ValueMkt cap + debt − cash | $2.8B | $508M |
| Trailing P/EPrice ÷ TTM EPS | 31.73x | 12.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 33.37x | 14.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 18.88x | 8.53x |
| Price / SalesMarket cap ÷ Revenue | 3.33x | 1.80x |
| Price / BookPrice ÷ Book value/share | 9.38x | 2.30x |
| Price / FCFMarket cap ÷ FCF | 32.57x | 63.83x |
Profitability & Efficiency
CRVL leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
CRVL delivers a 28.1% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $10 for AMSF. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CRVL's 0.09x. On the Piotroski fundamental quality scale (0–9), CRVL scores 8/9 vs AMSF's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +28.1% | +9.7% |
| ROA (TTM)Return on assets | +16.4% | +5.6% |
| ROICReturn on invested capital | +51.3% | +21.9% |
| ROCEReturn on capital employed | +39.5% | +16.8% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.09x | 0.00x |
| Net DebtTotal debt minus cash | -$143M | -$61M |
| Cash & Equiv.Liquid assets | $171M | $62M |
| Total DebtShort + long-term debt | $28M | $491,000 |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (Dividends Reinvested)
CRVL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRVL five years ago would be worth $14,573 today (with dividends reinvested), compared to $8,110 for AMSF. Over the past 12 months, AMSF leads with a -29.2% total return vs CRVL's -47.9%. The 3-year compound annual growth rate (CAGR) favors CRVL at -5.9% vs AMSF's -9.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -11.7% | -18.3% |
| 1-Year ReturnPast 12 months | -47.9% | -29.2% |
| 3-Year ReturnCumulative with dividends | -16.7% | -24.8% |
| 5-Year ReturnCumulative with dividends | +45.7% | -18.9% |
| 10-Year ReturnCumulative with dividends | +267.5% | +31.8% |
| CAGR (3Y)Annualised 3-year return | -5.9% | -9.1% |
Risk & Volatility
AMSF leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than CRVL's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMSF currently trades 62.4% from its 52-week high vs CRVL's 49.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.23x |
| 52-Week HighHighest price in past year | $117.22 | $48.54 |
| 52-Week LowLowest price in past year | $44.83 | $29.42 |
| % of 52W HighCurrent price vs 52-week peak | +49.5% | +62.4% |
| RSI (14)Momentum oscillator 0–100 | 46.5 | 34.2 |
| Avg Volume (50D)Average daily shares traded | 203K | 212K |
Analyst Outlook
CRVL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
AMSF is the only dividend payer here at 8.41% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $44.50 |
| # AnalystsCovering analysts | — | 6 |
| Dividend YieldAnnual dividend ÷ price | — | +8.4% |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $2.55 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +2.1% |
AMSF leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CRVL leads in 3 (Profitability & Efficiency, Total Returns).
CRVL vs AMSF: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CRVL or AMSF a better buy right now?
For growth investors, CorVel Corporation (CRVL) is the stronger pick with 12.
6% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRVL or AMSF?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus CorVel Corporation at 31. 7x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 4x.
03Which is the better long-term investment — CRVL or AMSF?
Over the past 5 years, CorVel Corporation (CRVL) delivered a total return of +45.
7%, compared to -18. 9% for AMERISAFE, Inc. (AMSF). Over 10 years, the gap is even starker: CRVL returned +267. 5% versus AMSF's +31. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRVL or AMSF?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 23β versus CorVel Corporation's 0. 48β — meaning CRVL is approximately 107% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 9% for CorVel Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CRVL or AMSF?
By revenue growth (latest reported year), CorVel Corporation (CRVL) is pulling ahead at 12.
6% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: CorVel Corporation grew EPS 24. 5% year-over-year, compared to -14. 5% for AMERISAFE, Inc.. Over a 3-year CAGR, CRVL leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRVL or AMSF?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus 10. 6% for CorVel Corporation — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 13. 5% for CRVL. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRVL or AMSF more undervalued right now?
On forward earnings alone, AMERISAFE, Inc.
(AMSF) trades at 14. 4x forward P/E versus 33. 4x for CorVel Corporation — 18. 9x cheaper on a one-year earnings basis.
08Which pays a better dividend — CRVL or AMSF?
In this comparison, AMSF (8.
4% yield) pays a dividend. CRVL does not pay a meaningful dividend and should not be held primarily for income.
09Is CRVL or AMSF better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, CRVL: +267. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRVL and AMSF?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CRVL is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock. AMSF pays a dividend while CRVL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.